282 related articles for article (PubMed ID: 17576665)
21. The DNA binding and 3'-end preferential activity of human tyrosyl-DNA phosphodiesterase.
Dexheimer TS; Stephen AG; Fivash MJ; Fisher RJ; Pommier Y
Nucleic Acids Res; 2010 Apr; 38(7):2444-52. PubMed ID: 20097655
[TBL] [Abstract][Full Text] [Related]
22. Novel Semisynthetic Derivatives of Bile Acids as Effective Tyrosyl-DNA Phosphodiesterase 1 Inhibitors.
Salomatina OV; Popadyuk II; Zakharenko AL; Zakharova OD; Fadeev DS; Komarova NI; Reynisson J; Arabshahi HJ; Chand R; Volcho KP; Salakhutdinov NF; Lavrik OI
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562592
[TBL] [Abstract][Full Text] [Related]
23. Substrate specificity of tyrosyl-DNA phosphodiesterase I (Tdp1).
Raymond AC; Staker BL; Burgin AB
J Biol Chem; 2005 Jun; 280(23):22029-35. PubMed ID: 15811850
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of fluorescent substrates for human tyrosyl-DNA phosphodiesterase I.
Rideout MC; Raymond AC; Burgin AB
Nucleic Acids Res; 2004; 32(15):4657-64. PubMed ID: 15333697
[TBL] [Abstract][Full Text] [Related]
25. Tyrosyl-DNA phosphodiesterase 1 (TDP1) repairs DNA damage induced by topoisomerases I and II and base alkylation in vertebrate cells.
Murai J; Huang SY; Das BB; Dexheimer TS; Takeda S; Pommier Y
J Biol Chem; 2012 Apr; 287(16):12848-57. PubMed ID: 22375014
[TBL] [Abstract][Full Text] [Related]
26. Processing of nucleopeptides mimicking the topoisomerase I-DNA covalent complex by tyrosyl-DNA phosphodiesterase.
Debéthune L; Kohlhagen G; Grandas A; Pommier Y
Nucleic Acids Res; 2002 Mar; 30(5):1198-204. PubMed ID: 11861912
[TBL] [Abstract][Full Text] [Related]
27. A fluorescence-based assay for the apurinic/apyrimidinic-site cleavage activity of human tyrosyl-DNA phosphodiesterase 1.
Thomson GJ; Hamilton NS; Hopkins GV; Waddell ID; Watson AJ; Ogilvie DJ
Anal Biochem; 2013 Sep; 440(1):1-5. PubMed ID: 23688965
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of the first dual tyrosyl-DNA phosphodiesterase I (Tdp1)-topoisomerase I (Top1) inhibitors.
Nguyen TX; Morrell A; Conda-Sheridan M; Marchand C; Agama K; Bermingham A; Bermingam A; Stephen AG; Chergui A; Naumova A; Fisher R; O'Keefe BR; Pommier Y; Cushman M
J Med Chem; 2012 May; 55(9):4457-78. PubMed ID: 22536944
[TBL] [Abstract][Full Text] [Related]
29. Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target.
Comeaux EQ; van Waardenburg RC
Drug Metab Rev; 2014 Nov; 46(4):494-507. PubMed ID: 25327705
[TBL] [Abstract][Full Text] [Related]
30. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
Liu C; Pouliot JJ; Nash HA
Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14970-5. PubMed ID: 12397185
[TBL] [Abstract][Full Text] [Related]
31. Biochemical assays for the discovery of TDP1 inhibitors.
Marchand C; Huang SY; Dexheimer TS; Lea WA; Mott BT; Chergui A; Naumova A; Stephen AG; Rosenthal AS; Rai G; Murai J; Gao R; Maloney DJ; Jadhav A; Jorgensen WL; Simeonov A; Pommier Y
Mol Cancer Ther; 2014 Aug; 13(8):2116-26. PubMed ID: 25024006
[TBL] [Abstract][Full Text] [Related]
32. Aminoadamantanes containing monoterpene-derived fragments as potent tyrosyl-DNA phosphodiesterase 1 inhibitors.
Ponomarev KY; Suslov EV; Zakharenko AL; Zakharova OD; Rogachev AD; Korchagina DV; Zafar A; Reynisson J; Nefedov AA; Volcho KP; Salakhutdinov NF; Lavrik OI
Bioorg Chem; 2018 Feb; 76():392-399. PubMed ID: 29248742
[TBL] [Abstract][Full Text] [Related]
33. Natural Products and Their Derivatives as Inhibitors of the DNA Repair Enzyme Tyrosyl-DNA Phosphodiesterase 1.
Zakharenko AL; Luzina OA; Chepanova AA; Dyrkheeva NS; Salakhutdinov NF; Lavrik OI
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982848
[TBL] [Abstract][Full Text] [Related]
34. Tyrosyl-DNA-phosphodiesterase I (TDP1) participates in the removal and repair of stabilized-Top2α cleavage complexes in human cells.
Borda MA; Palmitelli M; Verón G; González-Cid M; de Campos Nebel M
Mutat Res; 2015 Nov; 781():37-48. PubMed ID: 26421495
[TBL] [Abstract][Full Text] [Related]
35. Studying TDP1 Function in DNA Repair.
Chiang SC; Liversidge K; El-Khamisy SF
Methods Mol Biol; 2018; 1703():173-181. PubMed ID: 29177742
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.
Lv PC; Agama K; Marchand C; Pommier Y; Cushman M
J Med Chem; 2014 May; 57(10):4324-36. PubMed ID: 24800942
[TBL] [Abstract][Full Text] [Related]
37. A Dual-Sensor-Based Screening System for In Vitro Selection of TDP1 Inhibitors.
Jakobsen AK; Keller JG; Gonzalez M; Martin-Encinas E; Palacios F; Alonso C; Knudsen BR; Stougaard M
Sensors (Basel); 2021 Jul; 21(14):. PubMed ID: 34300575
[TBL] [Abstract][Full Text] [Related]
38. The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis.
Keil A; Frese-Schaper M; Steiner SK; Körner M; Schmid RA; Frese S
Arthritis Rheumatol; 2015 Jul; 67(7):1858-67. PubMed ID: 25779651
[TBL] [Abstract][Full Text] [Related]
39. Tyrosyl-DNA phosphodiesterase 1 targeting for modulation of camptothecin-based treatment.
Beretta GL; Cossa G; Gatti L; Zunino F; Perego P
Curr Med Chem; 2010; 17(15):1500-8. PubMed ID: 20166932
[TBL] [Abstract][Full Text] [Related]
40. Identification of novel inhibitors for the tyrosyl-DNA-phosphodiesterase 1 (Tdp1) mutant SCAN1 using virtual screening.
Mamontova EM; Zakharenko AL; Zakharova OD; Dyrkheeva NS; Volcho KP; Reynisson J; Arabshahi HJ; Salakhutdinov NF; Lavrik OI
Bioorg Med Chem; 2020 Jan; 28(1):115234. PubMed ID: 31831297
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
